Automating Cell Therapy Manufacturing
Fabian Gerlinghaus, CoFounder and Chief Executive Officer at Cellares, believes he can make autologous cell therapy a realistic proposition for solid tumors by closing and automating manufacturing
False
Fabian Gerlinghaus, CoFounder and Chief Executive Officer at Cellares, believes he can make autologous cell therapy a realistic proposition for solid tumors by closing and automating manufacturing
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
October 16, 2026
1 min read
Nucleome Therapeutics CTO Jonny Wray reveals how an engineer’s mindset can help navigate the complexity of human biology
October 5, 2026
4 min read
Regeneron's L. Andres Sirulnik explains why modernizing clinical trials is as important as developing new medicines
September 28, 2026
2 min read
Renee Aguiar-Lucander argues that faster clinical trials and more pragmatic regulation are essential to bringing medicines to patients sooner
September 9, 2026
5 min read
Lonza’s Wayne Wen discusses the growing maturity of China’s drug development and manufacturing ecosystem – and what companies need to compete internationally
False
Affiliations:
Specialties:
Areas of Expertise: